IP Library Granted Patent US 8,206,349
Granted Patent B2
US 8,206,349 · App. 11/680,781 · Granted Jun 26, 2012

Systems and methods for biofilm removal, including a biofilm removal endoscope for use therewith

Assignee: Medtronic Xomed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,206,349
App. No.
11/680,781
Granted
Jun 26, 2012
Kind
B2
Abstract

Systems and methods of removing bacterial biofilm from a target site using a biofilm removal endoscope. The endoscope has an insertion portion including an imaging channel terminating at a viewing window and an irrigation channel terminating at a nozzle. The imaging and irrigation channels are permanently affixed relative to one another. The insertion portion is inserted into the patient, with a working end thereof being disposed proximate the target site. The target site is imaged and a flow of fluid is dispensed via the nozzle to mechanically remove bacterial biofilm from the target site.

Claims (25)

1. A method of removing bacterial biofilm from a target site of a human patient, the method comprising:

providing a bacterial biofilm removal system including:

a biofilm removal endoscope having an insertion portion terminating at a working end, the insertion portion forming an imaging channel terminating at a viewing window disposed at the working end, and

an irrigation channel terminating at a nozzle carried at the working end and projecting distally beyond the viewing window, the imaging and irrigation channels -being permanently affixed relative to one another;

inserting the insertion portion into the patient;

disposing the working end proximate the target site, the target site including a layer of bacterial biofilm adhered to a surface;

imaging the target site with the biofilm removal endoscope via the viewing window; and

dispensing a flow of fluid directly toward the target site and away from the endoscope with the biofilm removal endoscope via the nozzle to mechanically remove a substantial portion of the layer of bacterial biofilm from the surface.

2. The method of claim 1 , wherein the insertion portion includes a flexible distal segment, and further wherein disposing the working end proximate the target site includes:

spatially articulating the distal segment relative to a handle of the endoscope to alter an angle of attack of the nozzle.

3. The method of claim 2 , wherein spatially articulating the distal segment includes:

delivering the working end to a first location relative to the target site;

evaluating a position of the nozzle when the working end is at the first location in subsequently performing a biofilm removal procedure based upon an obtained image; and

actuating an actuator external the patient to effectuate a bend in the distal segment to alter an angle of attack of the nozzle relative to the target site from a first angle of attack to a second angle of attack.

4. The method of claim 1 , further comprising:

aspirating the removed bacterial biofilm from the target site.

5. The method of claim 4 , wherein dispensing a flow of fluid and aspirating the removed bacterial biofilm occur simultaneously.

6. The method of claim 4 , wherein the insertion portion of the endoscope further forms an aspiration channel terminating at an aspiration inlet at the working end, the aspiration channel being permanently affixed relative to the imaging and irrigation channels, and further wherein the aspiration of the removed biofilm is facilitated by the biofilm removal endoscope via the aspiration inlet.

7. The method of claim 1 , wherein substantially all of the layer of bacterial biofilm is removed from the target site with the dispensed fluid.

8. The method of claim 1 , further comprising applying a medicament to the target site through the irrigation channel, the medicament adapted to interfere with bacterial biofilm regrowth.

9. The method of claim 8 , wherein the medicament is selected from the group consisting of: a surfactant, a gel, an antimicrobial, a steroid, a growth hormone, and combinations thereof.

10. The method of claim 1 , wherein the flow of fluid is directed through the nozzle at a flow rate from about 2 ml/sec to about 12 ml/sec.

11. The method of claim 1 , wherein the target site is within a sinus cavity.

12. The method of claim 1 , wherein the target site includes ciliated epithelium.

13. The method of claim 1 , wherein the method is performed in treating chronic rhinosinusitis.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2007
From: SLENKER, DALE E.; LEWIS, CECIL O.; NORMAN, GEROULD W.; PRISCO, JOHN R.
To: MEDTRONIC XOMED, INC.
Reel/Frame 019049/0546 →
Continuity (1)
Related Publication 20080214891A1 · Sep 4, 2008